Where others have failed will Atl1102 succeed ?, page-260

Well the stand off continues, we wait for the EMA approval. With an approval I would hope this will get us moving in the right direction from a SP perspective - hopefully closer to 30 - 40 cents. Then we would need to resolve funding, I know Diamond has been focused on stating non-dilutive but i still believe we will be diluted somewhat with a large parcel of the funding generated by new share offering

The question for me is if our MC is ~110m why wouldn't a large Pharma offer up 500m take over ? At that price its 5x current MC plus within the next 6 months i couldn't see many people knocking back an offer in this range. I know we have a 'potentially' game changing drug on our hands but its not on shelves yet so the risk reward at that value is pretty good i would have though